QIAGEN N.V. Announces $750 Million Non-US Offering of Convertible Bonds
QIAGEN N.V. announced a non-U.S. offering of net share settled convertible bonds on August 28, 2025. The company plans to issue senior, unsecured convertible bonds due in 2032. The aggregate volume of the issuance is USD 750 million, with each bond issued in minimum denominations of USD 200,000. The bonds may be converted in part into ordinary shares of the company, with approximately 11.2 million shares underlying the bonds, representing about 5.1% of QIAGEN's current issued and outstanding share capital. The expected settlement date for the bonds is September 4, 2025. QIAGEN intends to use the net proceeds from the issuance for general corporate purposes, including refinancing existing indebtedness. The bonds will be traded on the Open Market (Freiverkehr) segment of the Frankfurt Stock Exchange. The final terms, including price and interest rate, are expected to be determined and announced later on August 28, 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qiagen NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001015820-25-000062), on September 02, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.